Kandolf R, Sauter M, Aepinus C, Schnorr J J, Selinka H C, Klingel K
Department of Molecular Pathology, Institute for Pathology, University Hospital of Tübingen, Germany.
Virus Res. 1999 Aug;62(2):149-58. doi: 10.1016/s0168-1702(99)00041-6.
In humans and experimental murine models enteroviruses, and in particular coxsackieviruses of group B (CVB), may induce chronic myocarditis associated with a persistent type of heart muscle infection. Persistent myocardial infection has been characterized by restricted viral replication and gene expression, which is capable of sustaining chronic inflammation. Altered replication and transcription of the virus, in addition to an immune response insufficient to recognize and clear infected cells entirely, are essential mechanisms for initiation and maintenance of persistent heart muscle infection. Viral cytotoxicity was found to be crucial for organ pathology both during acute and persistent infection, indicating that enterovirus myocarditis is a virus-induced rather than an immune-mediated disease. Notably, resistance to the development of persistent heart muscle infection is not linked to the H-2 haplotype of the host. In addition to persistently infected myocytes, detection of the replicative minus-strand RNA intermediate provided evidence for virus replication in lymphoid cells of the spleen, predominantly in splenic B lymphocytes, during the course of the disease. Whereas viral RNA was also detected in certain CD4+ helper T cells and Mac1+ macrophages, no enteroviral genomes were identified in CD8+ T cells. Detection of infected activated B lymphocytes both in heart tissue of CVB3-infected immunocompetent mice and syngenic SCID mice receiving splenocytes from CVB3-infected donors support the concept that B cell traffic may contribute to maintenance of chronic disease. Dissection of the diversity of viral and host-specific determinants in susceptible and resistant hosts will allow us to define the protective mechanisms that mediate resistance to the development of life-threatening acute and chronic enterovirus myocarditis.
在人类和实验性小鼠模型中,肠道病毒,尤其是B组柯萨奇病毒(CVB),可能诱发与持续性心肌感染相关的慢性心肌炎。持续性心肌感染的特征是病毒复制和基因表达受限,但仍能维持慢性炎症。病毒复制和转录的改变,以及不足以完全识别和清除感染细胞的免疫反应,是持续性心肌感染发生和维持的重要机制。研究发现,无论是在急性感染还是持续性感染期间,病毒细胞毒性对器官病理变化都至关重要,这表明肠道病毒心肌炎是一种病毒诱导而非免疫介导的疾病。值得注意的是,对持续性心肌感染发展的抵抗力与宿主的H-2单倍型无关。除了持续感染的心肌细胞外,复制性负链RNA中间体的检测为疾病过程中脾脏淋巴样细胞(主要是脾脏B淋巴细胞)中的病毒复制提供了证据。虽然在某些CD4+辅助性T细胞和Mac1+巨噬细胞中也检测到了病毒RNA,但在CD8+T细胞中未发现肠道病毒基因组。在CVB3感染的免疫活性小鼠的心脏组织以及接受来自CVB3感染供体脾细胞的同基因SCID小鼠中均检测到感染的活化B淋巴细胞,这支持了B细胞迁移可能有助于维持慢性疾病的观点。剖析易感和抗性宿主中病毒和宿主特异性决定因素的多样性,将使我们能够确定介导对危及生命的急性和慢性肠道病毒心肌炎发展产生抗性的保护机制。